Cargando…
Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061093/ https://www.ncbi.nlm.nih.gov/pubmed/33861315 http://dx.doi.org/10.1182/blood.2021011904 |
| _version_ | 1783681495858151424 |
|---|---|
| author | Terpos, Evangelos Trougakos, Ioannis P. Gavriatopoulou, Maria Papassotiriou, Ioannis Sklirou, Aimilia D. Ntanasis-Stathopoulos, Ioannis Papanagnou, Eleni-Dimitra Fotiou, Despina Kastritis, Efstathios Dimopoulos, Meletios A. |
| author_facet | Terpos, Evangelos Trougakos, Ioannis P. Gavriatopoulou, Maria Papassotiriou, Ioannis Sklirou, Aimilia D. Ntanasis-Stathopoulos, Ioannis Papanagnou, Eleni-Dimitra Fotiou, Despina Kastritis, Efstathios Dimopoulos, Meletios A. |
| author_sort | Terpos, Evangelos |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8061093 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80610932021-04-22 Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose Terpos, Evangelos Trougakos, Ioannis P. Gavriatopoulou, Maria Papassotiriou, Ioannis Sklirou, Aimilia D. Ntanasis-Stathopoulos, Ioannis Papanagnou, Eleni-Dimitra Fotiou, Despina Kastritis, Efstathios Dimopoulos, Meletios A. Blood Letter to Blood American Society of Hematology 2021-07-01 /pmc/articles/PMC8061093/ /pubmed/33861315 http://dx.doi.org/10.1182/blood.2021011904 Text en © 2021 by The American Society of Hematology This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| spellingShingle | Letter to Blood Terpos, Evangelos Trougakos, Ioannis P. Gavriatopoulou, Maria Papassotiriou, Ioannis Sklirou, Aimilia D. Ntanasis-Stathopoulos, Ioannis Papanagnou, Eleni-Dimitra Fotiou, Despina Kastritis, Efstathios Dimopoulos, Meletios A. Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose |
| title | Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose |
| title_full | Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose |
| title_fullStr | Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose |
| title_full_unstemmed | Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose |
| title_short | Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose |
| title_sort | low neutralizing antibody responses against sars-cov-2 in older patients with myeloma after the first bnt162b2 vaccine dose |
| topic | Letter to Blood |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061093/ https://www.ncbi.nlm.nih.gov/pubmed/33861315 http://dx.doi.org/10.1182/blood.2021011904 |
| work_keys_str_mv | AT terposevangelos lowneutralizingantibodyresponsesagainstsarscov2inolderpatientswithmyelomaafterthefirstbnt162b2vaccinedose AT trougakosioannisp lowneutralizingantibodyresponsesagainstsarscov2inolderpatientswithmyelomaafterthefirstbnt162b2vaccinedose AT gavriatopouloumaria lowneutralizingantibodyresponsesagainstsarscov2inolderpatientswithmyelomaafterthefirstbnt162b2vaccinedose AT papassotiriouioannis lowneutralizingantibodyresponsesagainstsarscov2inolderpatientswithmyelomaafterthefirstbnt162b2vaccinedose AT sklirouaimiliad lowneutralizingantibodyresponsesagainstsarscov2inolderpatientswithmyelomaafterthefirstbnt162b2vaccinedose AT ntanasisstathopoulosioannis lowneutralizingantibodyresponsesagainstsarscov2inolderpatientswithmyelomaafterthefirstbnt162b2vaccinedose AT papanagnouelenidimitra lowneutralizingantibodyresponsesagainstsarscov2inolderpatientswithmyelomaafterthefirstbnt162b2vaccinedose AT fotioudespina lowneutralizingantibodyresponsesagainstsarscov2inolderpatientswithmyelomaafterthefirstbnt162b2vaccinedose AT kastritisefstathios lowneutralizingantibodyresponsesagainstsarscov2inolderpatientswithmyelomaafterthefirstbnt162b2vaccinedose AT dimopoulosmeletiosa lowneutralizingantibodyresponsesagainstsarscov2inolderpatientswithmyelomaafterthefirstbnt162b2vaccinedose |